Daily News

Most Recent

Animal eggs no good for cloning?

By | February 2, 2009

Gene expression differences suggest cloned human embryos are pluripotent but human-animal hybrids are not

0 Comments

Lost in translation?

By | January 29, 2009

A new book plots a course through the hinterland that lies between scientific innovation and commercial success

4 Comments

White noses hit PA brown bats

By | January 29, 2009

A deadly fungus has reached winged mammals in Pennsylvania

0 Comments

The lighter side of scientific fraud

By | January 28, 2009

A 34-year-old medical journal spoof is finally debunked

5 Comments

Rate your company, respond today

By | January 27, 2009

Got questions about our Best Places to Work in Industry survey, and why you should respond? We've got the answers

0 Comments

Geron CEO: Q&A

By | January 26, 2009

Thomas Okarma discusses the long and controversial path to harnessing the power of human embryonic stem cells

0 Comments

And then there were two

By | January 23, 2009

A cardiologist and a city health official lead the pack of potential FDA commissioners

0 Comments

Blogging biology

By | January 23, 2009

A high school biology teacher brings Web 2.0 into the classroom

5 Comments

The rainforest explained

By | January 16, 2009

A new book explores tropical treasure troves in words and images

0 Comments

Sequencing the extinct

By | January 12, 2009

Scientists sequence Tasmanian tiger mtDNA and pave the way for others to harvest ancient DNA from moldering museum specimens

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech